These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 37462223)
61. Berberine inhibits Smad and non-Smad signaling cascades and enhances autophagy against pulmonary fibrosis. Chitra P; Saiprasad G; Manikandan R; Sudhandiran G J Mol Med (Berl); 2015 Sep; 93(9):1015-31. PubMed ID: 25877860 [TBL] [Abstract][Full Text] [Related]
62. [Mechanism of total flavonoid extract from Dracocephalum moldavica on bleomycin-induced pulmonary fibrosis in mice based on pyroptosis pathway]. Lyu JM; Zhai KF; Duan H; Wang W; He CH Zhongguo Zhong Yao Za Zhi; 2022 Dec; 47(24):6663-6671. PubMed ID: 36604916 [TBL] [Abstract][Full Text] [Related]
64. Necrostatin-1 Alleviates Bleomycin-Induced Pulmonary Fibrosis and Extracellular Matrix Expression in Interstitial Pulmonary Fibrosis. Mou F; Mou C Med Sci Monit; 2020 Feb; 26():e919739. PubMed ID: 32019905 [TBL] [Abstract][Full Text] [Related]
65. Overcoming interferon (IFN)-γ resistance ameliorates transforming growth factor (TGF)-β-mediated lung fibroblast-to-myofibroblast transition and bleomycin-induced pulmonary fibrosis. Chang CJ; Lin CF; Lee CH; Chuang HC; Shih FC; Wan SW; Tai C; Chen CL Biochem Pharmacol; 2021 Jan; 183():114356. PubMed ID: 33285108 [TBL] [Abstract][Full Text] [Related]
66. Endostatin, an angiogenesis inhibitor, ameliorates bleomycin-induced pulmonary fibrosis in rats. Wan YY; Tian GY; Guo HS; Kang YM; Yao ZH; Li XL; Liu QH; Lin DJ Respir Res; 2013 May; 14(1):56. PubMed ID: 23688086 [TBL] [Abstract][Full Text] [Related]
67. MiR-200a inversely correlates with Hedgehog and TGF-β canonical/non-canonical trajectories to orchestrate the anti-fibrotic effect of Tadalafil in a bleomycin-induced pulmonary fibrosis model. Mansour SM; El-Abhar HS; Soubh AA Inflammopharmacology; 2021 Feb; 29(1):167-182. PubMed ID: 32914382 [TBL] [Abstract][Full Text] [Related]
68. [Effect of signal transducer and activator of transcription 1 antisense oligodeoxynucleotides on inflammatory mediators, type I and type III collagen mRNA of rat pulmonary fibrosis]. Wang WJ; Zeng M; Liu D; Fan XM; Zhu C; Zhan XQ Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 May; 25(5):389-92. PubMed ID: 19426591 [TBL] [Abstract][Full Text] [Related]
69. Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice. Gou S; Zhu T; Wang W; Xiao M; Wang XC; Chen ZH Int Immunopharmacol; 2014 Oct; 22(2):498-504. PubMed ID: 25111852 [TBL] [Abstract][Full Text] [Related]
70. Carnosol attenuates bleomycin-induced lung damage via suppressing fibrosis, oxidative stress and inflammation in rats. Kalantar H; Sadeghi E; Abolnezhadian F; Goudarzi M; Hemmati AA; Basir Z; Kalantar M Life Sci; 2021 Dec; 287():120059. PubMed ID: 34728227 [TBL] [Abstract][Full Text] [Related]
72. N-acetylcysteine downregulation of lysyl oxidase activity alleviating bleomycin-induced pulmonary fibrosis in rats. Li S; Yang X; Li W; Li J; Su X; Chen L; Yan G Respiration; 2012; 84(6):509-17. PubMed ID: 23006535 [TBL] [Abstract][Full Text] [Related]
74. Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-β-dependent epithelial to mesenchymal transition. Tang H; He H; Ji H; Gao L; Mao J; Liu J; Lin H; Wu T J Surg Res; 2015 Jul; 197(1):167-75. PubMed ID: 25911951 [TBL] [Abstract][Full Text] [Related]
75. Differential effects of pirfenidone on acute pulmonary injury and ensuing fibrosis in the hamster model of amiodarone-induced pulmonary toxicity. Card JW; Racz WJ; Brien JF; Margolin SB; Massey TE Toxicol Sci; 2003 Sep; 75(1):169-80. PubMed ID: 12832656 [TBL] [Abstract][Full Text] [Related]
76. Protective effect of hydroxysafflor yellow A on bleomycin- induced pulmonary inflammation and fibrosis in rats. Jin M; Wang L; Wu Y; Zang BX; Tan L Chin J Integr Med; 2018 Jan; 24(1):32-39. PubMed ID: 29294256 [TBL] [Abstract][Full Text] [Related]
77. [Anti-fibrotic effects of angiotensin1-7 on bleomycin-induced pulmonary fibrosis in rats]. Meng Y; Yu CH; Cai SX; Li X Zhonghua Yi Xue Za Zhi; 2013 May; 93(20):1585-9. PubMed ID: 24028731 [TBL] [Abstract][Full Text] [Related]
78. siRNA against plasminogen activator inhibitor-1 ameliorates bleomycin-induced lung fibrosis in rats. Zhang YP; Li WB; Wang WL; Liu J; Song SX; Bai LL; Hu YY; Yuan YD; Zhang M Acta Pharmacol Sin; 2012 Jul; 33(7):897-908. PubMed ID: 22659625 [TBL] [Abstract][Full Text] [Related]
79. Vasoactive intestinal peptide attenuates bleomycin-induced murine pulmonary fibrosis by inhibiting epithelial-mesenchymal transition: Restoring autophagy in alveolar epithelial cells. Duan JX; Guan XX; Yang HH; Mei WX; Chen P; Tao JH; Li Q; Zhou Y Int Immunopharmacol; 2021 Dec; 101(Pt B):108211. PubMed ID: 34634687 [TBL] [Abstract][Full Text] [Related]
80. [Effects of interleukin-11 antagonist on pulmonary fibrosis in mice]. Wu LX; Wu X Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2021 May; 37(3):308-312. PubMed ID: 34374245 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]